Yair Fisher
Technik-/Wissenschafts-/F&E-Leiter bei Glixogen Therapeutics Ltd.
Profil
Yair Fisher is currently the Chief Scientific Officer at GliXogen Therapeutics Ltd.
He holds a doctorate degree from Ben-Gurion University of the Negev.
Aktive Positionen von Yair Fisher
| Unternehmen | Position | Beginn |
|---|---|---|
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 |
Ausbildung von Yair Fisher
| Ben-Gurion University of the Negev | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
